Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.
OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation
Share with
Tagged in :
Leave a Reply